Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
GRACE is excited to share with you a partnership with Lilly Oncology to provide you information that reflects our shared interests.
We are happy to launch our Partnership Page with Lilly Oncology, available at https://cancergrace.org/sponsor/lilly-2020. This partnership highlights past and present GRACE information featuring our shared interests.
For more than 50 years, Lilly Oncology has been dedicated to life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. We share that commitment and appreciate the opportunity to encourage and further support our community!
On this partner page you will see information regarding biomarker testing, RET fusion + lung cancer and immunotherapy and chemotherapy combinations.
To learn more about Lilly Oncology please visit www.LillyOncology.com.
To join the conversation, visit our forums at https://cancergrace.org/forum.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…